Akarna Therapeutics is a startup based in the United Kingdom, most recent round Acquired, 1 tracked investor.
Akarna Therapeutics is a startup based in the United Kingdom. Akarna Therapeutics has been acquired. Brouky records 1 investor associated with the company.
Akarna Therapeutics was a biopharmaceutical company developing novel small molecule therapeutics targeting inflammatory and fibrotic diseases, with its lead program focusing on a potential best-in-class FXR agonist for the treatment of non-alcoholic steatohepatitis (NASH).
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.